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for Medical Sciences andWith the aging of the world’s population and the well-
advanced epidemiological transition that is occurring in
low- and middle-income countries (LMICs), the major
burden of global diseases now lies with noncommunicable
diseases (NCDs). Funding in global health, however, re-
mains focused on human immunodeficiency virus, tuber-
culosis, and malaria with no equivalent PEPFAR
(President’s Emergency Plan for AIDS Relief) or Global
Fund to support research and implementation practices to
decrease the burden of NCDs, or provide new solutions to
deliver impact. To prepare for the next global health ob-
jectives, the Global Alliance for Chronic Disease (GACD)
brought together local funders to combine forces to enlarge
the network of researchers in NCDs.
The GACD was formed from its precursor, the Grand
Challenges Global Partnership, funding implementation
science research with the aim of improving uptake and
scale-up of well-evidenced approaches to prevention and
control of NCDs, rather than developing new treatments
[1]. In 2010, the GACD’s member funding agencies
collaborated on the first unified funding call for imple-
mentation research projects, which focused explicitly on
implementation and evaluation of evidence-based ap-
proaches to address the burden of hypertension in LMICs
and in indigenous (in the case of Australia and Canada)
settings. Beyond a traditional research funding call, the
GACD aspired to create something distinct from each in-
dividual funding agency’s usual funding schemes—an in-
ternational research collaboration that would collectively
contribute new and actionable knowledge and catalyze
research to address the growing global NCD burden.
As the initial hypertension program finishes, it is
timely to reflect on the lessons learned, the maturation that
has occurred, and the contribution that the GACD is
making to multicountry, global implementation research.Technology, Trivandrum,
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An expectation of GACD funding for the duration of the
grant is attendance by at least 1 representative each from a
high-income country (HIC) and an LMIC at the annualGLOBAL HEART, VOL. 14, NO. 4, 2019
December 2019: 391-394scientific meeting (ASM). By requiring attendance, and
ring-fencing funding for attendance in the project budgets,
the GACD has facilitated a unique collaborative context.
Also attending these ASMs are the GACD board members,
funding agency representatives, and secretariat staff.
At the ASMs, a mix of senior, midcareer, and early
career researchers attend with good representation from
both HICs and LMICs. Initially, it was just the hyper-
tension research teams with 40 to 50 attendees; as other
research consortia were funded (including Diabetes,
Mental Health, and Lung Disease) attendance reached up
to 150 at the 2018 meeting in São Paulo, Brazil. It is also
common for GACD-funded research teams send addi-
tional team members to these annual meetings, often
funded out of alternate funding mechanisms. Moreover,
some researchers from the inaugural GACD Program
(Hypertension) have continued to attend ASMs despite
their project’s (and funding) completion, reinforcing the
value of these meetings and the ongoing knowledge
transfer between cohorts over time. The size of these
meetings, smaller than a traditional scientific conference,
also provides an excellent opportunity for researchers to
discuss not only their specific research projects, but also
shared learnings and challenges, at a level not always
possible in larger contexts.
At each ASM, the Secretariat invites experts such as
local policy makers and Ministry of Health representatives,
funding body representatives who give presentations, in-
vestors such as the World Bank, and specialists in media
training. Access to such expertise and training opportu-
nities is often challenging for researchers, particularly to
those from LMICs; consequently, these components are
highly valued.COLLABORATIVE ACTIVITIES
The most-cited benefit by participants at the annual
meetings has been the networking opportunities. Coming
to the meetings where there was a relatively small number
of people (compared with a scientific meeting or confer-
ence), staying together in the same hotel, sharing meals,391
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392and mingling over morning tea created important oppor-
tunities to foster networks, percolate ideas, build relation-
ships, and have dedicated time to evolve these discussions
into more specific collaborative activities in the future.
Table 1 summarizes these activities and their opportunities
for early career and midcareer researchers.
COLLABORATIVE OUTCOMES
The outcomes and impact of this collaborative context have
been multiple.
Publications
The field of Implementation Science focusing on research
in LMICs was still emerging as a field when the GACD was
first established in 2009. In total, the hypertension-funded
teams have so far published 75 papers across a range of
scientific journals, thus contributing significantly to the
implementation science literature.
Implementation Science Workshop
An Implementation Science Workshop, in conjunction
with the ASM, was initiated and open to any funded re-
searchers as well as local researchers from the host country.
These workshops use a case study approach, with prag-
matic discussions and. Topics include “What is an imple-
mentation trial?”; design and conduct of hybrid
implementation-effectiveness studies; sharing of chal-
lenges of working in low-resource settings; and the
importance of understanding process evaluation of com-
plex interventions so as to understand “what worked, for
whom, why, and why not.” Since 2014, >450 researchers
have been trained with the majority of attendees being
women (57%) and from LMICs (67%), reflecting diversity
and inclusion as part of the GACD’s capacity building
program. Several workshops have also been held separate
from the ASM stemming from enthusiasm to access this
expertise and provide local training opportunities for other
researchers.
Network extensions
Stemming from hosting of the Seventh Implementation
Science workshop in Tokyo, Japan, in 2018, a formal
implementation science research network has been estab-
lished in Japan. The RADISH (Research Association for
Dissemination and Implementation Science in Health) has
held their inaugural meeting with 120 attendees and plans
to establish regular meetings and workshops, establish a
reading circle to discuss implementation science books and
methods, and disseminate relevant research opportunities
and evidence to its member base.
Additionally, the Brazilian Implementation Science
Network has been established following the inaugural
GACD Implementation Science weeklong training school
held in Brazil in 2018. Their goals include establishing
formal relationships between the GACD and Brazilianresearch funding agencies, host annual collaborative
meetings to foster collaborations in implementation sci-
ence, and provide a platform to enhance collaborative IS
implementation science.Special interest working groups
Access to wider skillsets catalyzed the formation of working
groups addressing areas of common interest. Several
groups had a methodological focus such as process eval-
uation methods, task shifting or sharing as a health
strengthening tool, frameworks for determining barriers,
and enablers to implementation [2,3]. The COUNCIL
(Control UNique to Cardiovascular diseases In LMIC)
initiative started with the aim of reviewing the relevance of
current cardiovascular disease guidelines for LMIC settings
and developing an implementation pipeline for pragmatic
solutions to the cardiovascular disease burden in LMICs
[4]. The COUNCIL initiative has now also included other
chronic NCDs including diabetes [5], stroke [6], obesity,
chronic obstructive pulmonary disorder, and depression.
The data consensus group aimed to develop consensus
measures for data collection [7] and ensured an improve-
ment in the commonality of data points collected across
the projects, as well as improved consistent definitions
across projects. This enhanced dataset is a significant op-
portunity for future collaborative meta-analysis.CHALLENGES AND OPPORTUNITIES FOR
IMPROVEMENT
Despite significant successes and positive outcomes from
this innovative and novel approach by the GACD, there
have also been limitations and challenges.
Highly successful researchers working in the compet-
itive research funding environment may have challenges
with “required” collaboration. The strong leadership by the
GACD secretariat helped to keep the teams “on the same
page,” managing differences in personality, approaches,
and ideas about methodology.
Additionally, at times there were many “asks” of the
researchers and many opportunities for involvement in the
GACD that, although generally positive, needed to be
balanced with “opportunity cost.” It could be challenging
to know where to focus attention without losing sight of
the main goal, which was delivering the funded project on
time and within budget.
A final challenge is occurring with the success of the
GACD program as additional members from Diabetes, Lung
Disease and Mental Health funding calls are added to the
annual meeting which is becoming quite large. Conse-
quently, the opportunity to connect as a small, intimate
group has diminished. The secretariat is now challenged
with designing the agenda to maximize useful discussion
without the meeting becoming a never-ending series of
projects simply presenting their respective updates.GLOBAL HEART, VOL. 14, NO. 4, 2019
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TABLE 1. Networking and collaborative opportunities of the GACD program
ASM Impact Example
Informal mentoring
opportunities
 Senior colleagues sharing wisdom over a shared dinner or during coffee breaks
Example: Multiple examples of E/MCRs encouraged to persevere despite a challenging
research funding environment.
Learning opportunities  Access to a variety of different skills at the right time
Example: One LMIC investigator was successful in obtaining a local country grant spe-
cifically due to enhancement of expertise with participation in the GACD hypertension
program.
Example: An LMIC investigator has consequently had secondary involvement in an
external regional expert group due to collaborations as part of the GACD hypertension
program.
 Capacity to learn from other researchers, countries, and contexts. Hearing from the
different contexts is helpful for cross-fertilization of ideas.
Example: The LARK study in Kenya incorporated process evaluation into their study after
hearing about it in detail at one ASM [8].
Example: Access to expertise in theory-driven conceptual models enabled deeper
understanding of contexts within which research was being conducted and also assisted
with generalized learning across projects [9].
Collaboration/networking across
countries and continents
 Valuable networking opportunities not only for LMIC researchers with HICs, but also
for so-called south-south collaborations between LMICs
Example: New collaboration between Christian Medical College Vellore, Sree Chitra
Tirunal Institute for Medical Sciences and George Institute, India.
Example: LMIC researcher from India identified 2 senior sponsors for an international
fellowship opportunity.
Example: Eight copublished papers across different teams.
 Geographically isolated E/MCRs from HICs such as Australia, where networking op-
portunities with northern hemisphere colleagues are more challenging due to high
cost and long travel times to attend conferences and meetings.
Examples: Co-supervision of students across geographical regions between the United
States and Australia.
Example: Invited presentation for Australian ECR visiting the United States.
Collaborating  Unique opportunity to collaborate and bounce ideas off other researchers with
complementary experience and skill sets to expand the breadth and potential of
future research projects.
Example: Co-applicants on grants in different research areas.
Quote from one researcher: “There is magnanimity of researchers, no one is competing,
and we’re all funded. Usually at a conference you showcase your final product and
you’re making it look good. Here we are living together all the things that happened on
the way. Everyone is giving what they can give so that we can all learn from each other.”
Access to policymakers
and decision makers
 GACD board members and funding agency representatives
Example: The challenges of grantsmanship in the area of Implementation Science was
discussed openly with funding body representatives. Funding agency reviewers often
expect “gold standard” RCTs, even when these are impractical or not the most appro-
priate methodology for implementation science. Subsequent funding calls were modified
in response to this. In addition, a multidisciplinary, centralized grant review process
comprising representatives nominated from several of the GACD funding bodies was
ultimately implemented.
 Policymakers
Example: Policy roundtable held in each Implementation Science workshop, in which
policymakers and program implementers engaged in practical discussions with re-
searchers on moving their research findings to policy and practice
Example: United Nations High Level meeting on NCDs—invitations to participate on
panels.
 Philanthropic organizations
(continued)
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TABLE 1. Continued
ASM Impact Example
Opportunities for growth  For many projects, the senior investigators stepped aside and allowed involvement of
E/MCRs. This created capacity for more junior researchers to have a leading role on
papers, or chairing a working group, thus building their profile as an independent
researcher.
Example: The Council working group was set up by an LMIC researcher with a specific
remit to assess availability and quality of guidelines relevant to LMICs.
Example: The Process Evaluation working group was initiated by a then junior LMIC
researcher who, with the support and guidance of more experienced colleagues, has
developed guidelines for process evaluation as well as a manuscript describing the
approaches and learnings of GACD projects’ process evaluations.
ASM ¼ annual scientific meeting; ECR ¼ Early Career Researcher; E/MCR ¼ Early/Mid Career Researcher; GACD ¼ Global Alliance for Chronic Disease;
HIC ¼ high-income country; LMIC ¼ low- and middle-income country; NCD ¼ noncommunicable disease; RCT ¼ Randomised Controlled Trial.
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394NEXT STEPS
Moving forward, the GACD is already expanding the
network by bringing on board different disease areas such
as lung diseases and mental health, and most recently
hosting a funding call to support scale up projects
involving proven interventions. However, over and above
these initiatives, additional priorities should include
consideration for how the GACD might support the
maintenance of these networks. Without the facilitative
context of the Annual Scientific Meeting, the risk is that the
networks will slowly wither and die. Inclusion of GACD
alumni in future scientific meetings, scholarships for LMIC
members to continue to attend the ASM, and active
sponsorship by the GACD board and secretariat to pro-
mote use of the GACD networks for occasions, such as
invited presentations, expert advisory boards, or other
academic endeavors, would be highly valuable.
The legacy of the GACD Hypertension Program is not
only the relationships and friendships formed, but also the
documented contribution to the field of implementation
science in NCDs; provision of supported learning oppor-
tunities regardless of career stage, discipline, or country of
residence; and unprecedented access to funders, policy-
makers, and other decision makers. With a fully established
new global network of NCD researchers, over 200 million
committed in funding, global representation, multiple
internationally competitive publications, and new south-
south collaborations, the value-add of this novel funding
approach is that this group of researchers has truly become
more than the sum of the parts. Without a doubt, this
network is significantly contributing to the lowering ofcardiovascular risk factors and thereby prolonging life in
those at greatest need globally.REFERENCES
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